ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 689

Association of Kinesiophobia, Aerobic Exercise, Functional Impairment and Disease Activity of Patients with Rheumatoid Arthritis and Spondyloarthritis

Daniele Peres1, Nicolas Tordi2, Daniel Wendling3, Yoshimasa Sagawa4 and Clément Prati5, 1EA 4267 PEPITE (FHU INCREASE) – Plateforme EPSI, Université de Bourgogne Franche-Comté, Besançon,, France, 2PEPITE EA 4267, Bourgogne Franche-Comté University, Besançon, France, 3Rheumatology, University Hospital - Bourgogne Franche Comté University, Besançon, France, 4Laboratoire de l'Exploration Fonctionnelle et Clinique du Mouvement (LEFCM), BESANCON, France, 5Rheumatology, University Hospital - Bourgogne Franche Comté University, Besancon, France

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS), exercise and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Imaging, Clinical Studies, and Treatment

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Association of kinesiophobia, aerobic exercise, functional impairment and disease activity of patients with rheumatoid arthritis and spondyloarthritis.

Background/Purpose:

 Rheumatoid arthritis (RA) and spondyloarthritis (SA) are the most common chronic inflammatory rheumatism, leading to functional disability, but also cardiovascular mortality. Aerobic exercise (AE) is one of the most effective non-pharmacological resources for cardiovascular rehabilitation  while the patients RA and SA have difficulty to join the practice of physical exercise. It can be explained by the presence of kinesiophobia, fear that the movement exacerbates the pain and disease

The objective was to compare the level of AE of patients with RA and SA with healthy subjects and to verify the association between kinesiophobia, the level of activity of the disease and the functional disability.

Methods:

Fifty RA patients and fifty SA patients followed by the rheumatology department of the University Hospital of Besançon and fifty healthy age-matched subjects were included. The main inclusion criteria: between 18 and 80 years old and without orthopedic surgery <1 year. The disease activity (DAS-28 and ASDAS), the functional disability (HAQ and BASFI), the level of AE (SQUASH questionnaire) and kinesiophobia (TSK questionnaire) were evaluated. The control group answered to the SQUASH questionnaire. The t-test was used to compare inflammatory rheumatism groups with the control group (healthy subjects). The Pearson Correlation Test for each group (RA and SA) was used to verify the associations between variables.

Table 1: Demographic Characteristics of Patients with RA and SA and Healthy Subjects.

RA

SA

Healthy Subjects

Age (years)

62.8 (10.8)

47.3 (12.7)

55.7 (13.4)

  Height (m)

1.66 (0.10)

1.70 (0.1)

1.70 (0.1)

Weight (Kg)

72.4 (16.5)

71.8 (14.7)

71.7 (14.8)

Aerobic Exercises (SQUASH)

3706.9 (2958.3)

5448.0 (3655.6)

5503.5 (3095.9)

Kinesiophobie (TSK )

42.7 (7.8)

40.6 (7.5)

–

Functional disability (HAQ/BASFI)

1.0 (0.6)

4.3 (2.4)

–

Disease activity (DAS28/ASDAS)

3.0 (1.1)

1.6 (1.1)

–

Results:

 The level of AE is significantly higher in healthy subjects (p = 0.022). In the RA group, kinesiophobia is associated with disease activity, functional disability and level of AE. In the SA group, kinesiophobia is associated only with the functional disability.

Table 2: Results of Pearson Correlation Test between variables

* p <0.005; ** p < 0,005

Aerobic Exercice

Kinesiophobie

Functional Disability

Disease Activity

RA

Aerobic Exercise

–

r = -0.280*

r = -0.414**

r = -0.149

Kinesiophobie

r = -0.280*

–

r = 0.522**

r = 0.327*

Functional Disability

r = -0.414**

r = 0.522**

–

r = 0.531*

SA

Aerobic Exercise

–

r = -0.165

r = -0.40

r = -0.064

Kinesiophobie

r = -0.165

–

r = 0.345*

r = 0.224

Functional Disability

r = -0.040

r = 0.345*

–

r = 0.737**

Patients have a low level of AE compared to healthy subjects. However, only the RA group has an association between kinesiophobia and AE. In the SA group, functional disability appears to be a factor limiting the practice of AE.

Conclusion:

RA and SA patients need to be encouraged and better informed about the benefits of physical exercise.


Disclosure: D. Peres, None; N. Tordi, None; D. Wendling, None; Y. Sagawa, None; C. Prati, None.

To cite this abstract in AMA style:

Peres D, Tordi N, Wendling D, Sagawa Y, Prati C. Association of Kinesiophobia, Aerobic Exercise, Functional Impairment and Disease Activity of Patients with Rheumatoid Arthritis and Spondyloarthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/association-of-kinesiophobia-aerobic-exercise-functional-impairment-and-disease-activity-of-patients-with-rheumatoid-arthritis-and-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/association-of-kinesiophobia-aerobic-exercise-functional-impairment-and-disease-activity-of-patients-with-rheumatoid-arthritis-and-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology